Relapse autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells T-Lymphocytes Neural Stem Cells Bone Marrow Cells Induced Pluripotent Stem Cells Cells, Cultured Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Neoplastic Stem Cells Spermatogonia Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases55

Multiple Myeloma Recurrence Hodgkin Disease Lymphoma, Non-Hodgkin Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Leukemia, Myeloid, Acute Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Lymphoma, B-Cell Leukemia, Plasma Cell Neoplasms, Second Primary Leukemia, Myeloid Neoplasm Recurrence, Local Leukemia Acute Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Neutropenia Disease Progression Hepatic Veno-Occlusive Disease Lymphoma, AIDS-Related Neuroblastoma Hematologic Diseases Neoplasms Leukemia, Myelogenous, Chronic, BCR-ABL Positive Stomatitis Cytomegalovirus Infections Breast Neoplasms Anemia, Aplastic Mucositis Infection Severe Combined Immunodeficiency Chromosome Aberrations Medulloblastoma Lymphoproliferative Disorders Opportunistic Infections Central Nervous System Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Disease Models, Animal Postoperative Complications Thrombocytopenia Paraproteinemias Blood Group Incompatibility Chronic Disease Mycoses Roseolovirus Infections Bronchiolitis Obliterans Epstein-Barr Virus Infections

Chemicals and Drugs50

Melphalan Etoposide Myeloablative Agonists Cytarabine Cyclophosphamide Carmustine Vincristine Thiotepa Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antigens, CD34 Doxorubicin Thalidomide Antineoplastic Agents, Alkylating Prednisone Ifosfamide Podophyllotoxin Granulocyte Colony-Stimulating Factor Antineoplastic Agents Idarubicin Mitoxantrone Immunosuppressive Agents Keratins, Type II Antibodies, Monoclonal Carboplatin Immunoglobulin Light Chains Vidarabine HLA Antigens Cisplatin Antilymphocyte Serum Immunoconjugates Bleomycin Stem Cell Factor Cyclosporine Recombinant Proteins Minor Histocompatibility Antigens Methotrexate Prednisolone Antigens, CD Immunologic Factors Antigens, CD20 Tacrolimus Biological Markers Nitrogen Mustard Compounds Myeloma Proteins Antibodies, Neoplasm Methylprednisolone

Analytical, Diagnostic and Therapeutic Techniques and Equipment92

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Salvage Therapy Disease-Free Survival Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Survival Rate Bone Marrow Purging Whole-Body Irradiation Retrospective Studies Survival Analysis Prognosis Follow-Up Studies Liver Transplantation Mesenchymal Stem Cell Transplantation Leukapheresis Induction Chemotherapy Cord Blood Stem Cell Transplantation Maintenance Chemotherapy Cell Transplantation Kidney Transplantation Infusions, Spinal Blood Component Removal Histocompatibility Testing Prospective Studies Feasibility Studies Life Tables Fatal Outcome Radioimmunotherapy Risk Factors Heart Transplantation Lung Transplantation Drug Administration Schedule Immunotherapy Blood Transfusion, Autologous Lymphocyte Transfusion Organ Transplantation Transplantation, Isogeneic Kaplan-Meier Estimate Clinical Trials as Topic Flow Cytometry Treatment Failure Transplantation Immunosuppression Neoplasm Staging Islets of Langerhans Transplantation Pilot Projects Lymphocyte Depletion Positron-Emission Tomography Cell Separation Immunophenotyping Predictive Value of Tests Pancreas Transplantation Platelet Count Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Cell Culture Techniques Transplantation, Heterologous Immunomagnetic Separation Stem Cell Research Multivariate Analysis Proportional Hazards Models Leukocyte Count Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Cohort Studies Disease Models, Animal Transplantation, Heterotopic Colony-Forming Units Assay Radiotherapy Polymerase Chain Reaction Immunotherapy, Adoptive Platelet Transfusion Leukocyte Transfusion Incidence Lymphocyte Count Heart-Lung Transplantation Reverse Transcriptase Polymerase Chain Reaction Blood Cell Count Actuarial Analysis Drug Therapy Cell Count Immunohistochemistry

Psychiatry and Psychology1

Phenomena and Processes27

Graft Survival Time Factors Cell Differentiation Histocompatibility Graft vs Leukemia Effect Hematopoiesis Transplantation Immunology Stem Cell Niche Graft Rejection Graft vs Tumor Effect Dose-Response Relationship, Drug Chimerism Cell Lineage Platelet Count Cell Proliferation Regeneration Transplantation Tolerance Immunocompromised Host Chromosome Aberrations Virus Activation Leukocyte Count Cell Survival Lymphocyte Count Blood Cell Count Drug Resistance, Neoplasm Cell Count Phenotype

Disciplines and Occupations3

Stem Cell Research Immunohistochemistry Regenerative Medicine

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Life Tables Fatal Outcome Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Retrospective Studies Survival Analysis Follow-Up Studies Prospective Studies Feasibility Studies Life Tables Fatal Outcome Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Predictive Value of Tests Age Factors Donor Selection Severity of Illness Index Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Cohort Studies Incidence Tissue and Organ Procurement Actuarial Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Remission Induction Treatment Outcome Stem Cells Salvage Therapy Recurrence Disease-Free Survival Hodgkin Disease Etoposide Myeloablative Agonists Lymphoma, Non-Hodgkin Cytarabine Cyclophosphamide Graft vs Host Disease Carmustine Bone Marrow Transplantation Hematopoietic Stem Cell Mobilization Vincristine Survival Rate Bone Marrow Purging Thiotepa Hematologic Neoplasms Lymphoma, Mantle-Cell Whole-Body Irradiation Retrospective Studies Survival Analysis Amyloidosis Hematopoietic Stem Cells Busulfan Boronic Acids Dexamethasone Pyrazines Graft Survival Prognosis Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Follow-Up Studies Autografts Antigens, CD34 Lymphoma, T-Cell, Peripheral Doxorubicin Liver Transplantation Thalidomide Antineoplastic Agents, Alkylating Mesenchymal Stem Cell Transplantation Prednisone Leukapheresis Ifosfamide Time Factors Podophyllotoxin Lymphoma Granulocyte Colony-Stimulating Factor Transplantation Chimera Neoplasm, Residual Induction Chemotherapy Lymphoma, Large B-Cell, Diffuse Tissue Donors Cord Blood Stem Cell Transplantation Maintenance Chemotherapy Leukemia, Myeloid, Acute Cell Transplantation Antineoplastic Agents Kidney Transplantation Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Myelodysplastic Syndromes Lymphoma, B-Cell Idarubicin Infusions, Spinal Leukemia, Plasma Cell Mitoxantrone Neoplasms, Second Primary Adult Stem Cells Immunosuppressive Agents Blood Component Removal Histocompatibility Testing Prospective Studies Leukemia, Myeloid Keratins, Type II Cell Differentiation Histocompatibility Antibodies, Monoclonal Feasibility Studies Neoplasm Recurrence, Local Life Tables Mesenchymal Stromal Cells Fatal Outcome Graft vs Leukemia Effect Carboplatin Leukemia Radioimmunotherapy

No FAQ available that match "relapse autologous stem cell transplantation"